Skip to main content

Published locations for Optimizing therapy in relapsed CLL: ibrutinib and beyond

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Optimizing therapy in relapsed CLL: ibrutinib and beyond

User login

  • Reset your password
  • /content/optimizing-therapy-relapsed-cll-ibrutinib-and-beyond
  • /hematologynews/article/141148/cll/optimizing-therapy-relapsed-cll-ibrutinib-and-beyond
  • /oncologypractice/article/141148/cll/optimizing-therapy-relapsed-cll-ibrutinib-and-beyond
  • /hematology-oncology/article/141148/cll/optimizing-therapy-relapsed-cll-ibrutinib-and-beyond
  • /b-cell-lymphoma-icymi/article/141148/cll/optimizing-therapy-relapsed-cll-ibrutinib-and-beyond